(Total Views: 675)
Posted On: 01/17/2022 11:51:24 AM
Post# of 153974
Janet Woodcock's testimony before the Senate Health Committee on the FDA's Response to Omicron:
“There’s an extreme unmet medical need for therapeutics at most stages of the disease, particularly in the late stages, where we still don’t have interventions and people are dying, going into the ICU and going on the ventilator,” Woodcock said, noting there are 670 INDs that are ongoing. “Robust development is still ongoing in the therapeutic area.”
https://endpts.com/woodcock-defends-fdas-resp...committee/
“There’s an extreme unmet medical need for therapeutics at most stages of the disease, particularly in the late stages, where we still don’t have interventions and people are dying, going into the ICU and going on the ventilator,” Woodcock said, noting there are 670 INDs that are ongoing. “Robust development is still ongoing in the therapeutic area.”
https://endpts.com/woodcock-defends-fdas-resp...committee/
(3)
(0)
